The present invention provides primers for detection and differentiation of FPV, CPV, and/or CPV types present in a sample in a single reaction. The present invention also provides a process for detection and differentiation of FPV, CPV and/or CPV types.
The present invention relates to detection and serotyping of foot and mouth disease virus (FMDV) using a novel set of oligonucleotides as diagnostic tools. The oligonucleotides of the present invention have nucleotide sequences as set forth in SEQ ID NO: 1 to SEQ ID NO: 18. The present invention provides a kit for t...
The present invention provides a method for generating a recombinant human anti-Rabies monoclonal antibody comprising Fab fragment. The invention further provides a recombinant human anti-Rabies monoclonal antibody comprising Fab fragment capable of specifically binding to rabies virus glycoprotein and their use in ...
A monovalent anti-Brucella S-LPS antibody is disclosed herein. In particular, the present invention relates to scFv antibody that enables the detection of Brucella S-LPS antigen in a biological sample. The present invention further provides recombinant DNA vector, and recombinant host cell comprising the polynucleot...
The present disclosure relates to the process of synthesis of a single chain variable fragment (scFv) antibody from murine immunized library that is specific and reactive against rabies CVS glycoprotein. In particular, the present disclosure relates to scFv antibody that enables the detection of rabies CVS antigen i...
Present invention provides a process for detection and serotyping of Foot-and- outh Disease Virus (FMDV) in a sample using sandwich ELISA method. The present invention particularly discloses a process for detection and serotyping of FMDV using the monoclonal antibodies and chiken IgY antibodies specific to FMDV ser...
The present invention describes a process of production of a live attenuated vaccine against sheep pox virus (SPV). The process disclosed in the present invention involves adaptation and modification i. e. further attenuation of the virus in Vero cell line. The vaccine composition produced by the process disclosed i...
The present invention disclose a process for detection and differentiation of food and Mouth disease Virus (FMDV) serotypes in a sample. The present invention also disclose a detection kit for detection of FMDV and differentiating the antigenic serotypes in a test sample obtained from clinical or biological samples ...
The present invention relates to a novel nucleic acid sequence (HPV16 L1S) encoding antigenic HPV16 LI protein as provided in SEQ ID NO: 1, wherein the said sequence has at least one modified codon for optimum stability of recombinant plasmid vector when transformed in the prokaryotic micro-organism for improved imm...
The present invention relates to the development of a novel vaccine candidate comprising of a conjugate vaccine alone or in combination with plasmid DNA or inactivated or live attenuated whole Brucella organism which can be used as a prophylactic or a therapeutic vaccine in target species such as cattle and buffaloe...
The present invention provides recombinant human bivalent diabody against rabies virus capable of recognizing rabies virus glycoprotein and neutralizing rabies viruses and a method for production thereof. The present invention further provides polynucleotide encoding the recombinant bivalent diabody. The bivalent di...
The present invention relates to generation of monovalent antibody fragment, single chain variable fragment (ScFv) from human immunised library having one antigen binding site that is reactive against the Hepatitis A virus which can be used as a diagnostic tool. The present invention particularly provides monovalent...
A recombinant monoclonal anti-bovine IgA antibody is disclosed herein. The anti-bovine IgA antibody as disclosed is scFv. The present invention further provides a recombinant vector comprising the polynucleotide encoding the recombinant antibody and a host comprising the vector. The anti-bovine IgA antibody as discl...
A monovalent anti-canine parvovirus antibody is disclosed herein. The anti-canine parvovirus antibody as disclosed is scFv. The present invention further provides a recombinant vector and a host comprising the vector. The anti-canine parvovirus antibody as disclosed herein shows strong binding to canine parvovirus. ...
The present disclosure provides a scalable step-wise process for purification of diphtheria toxoid that is faster, and provides reduced process variability in toxoid retention.
The present disclosure provides a scalable step-wise process for purification of tetanus toxoid that is faster, and provides reduced process variability in toxoid retention.
[Class : 9] Software,Application Software,Education Software,Health Advisory Software,E Books,E Book Reader,Audio And Video Book Featuring Education,Health Material For Children And Parents,Downloadable Digital Content In The Form Of Electronic Publications Of Book,Downloadable Digital Content In The Form Of Electronic Publications Of Brochures,Downloadable Digital Content ...